Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 3901-3950 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06863272
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
PHASE1/PHASE2Recruiting
360 participants
Started: Jul 3, 2025 · Completed: Feb 24, 2030
2 conditions2 sponsors35 locations
NCT05910580
Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years
NARecruiting
400 participants
Started: Jul 3, 2025 · Completed: May 31, 2027
10 conditions4 sponsors4 locations
NCT06920134
Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease
NARecruiting
5 participants
Started: Jul 3, 2025 · Completed: May 1, 2031
5 conditions1 sponsor1 location
NCT07061652
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
NARecruiting
162 participants
Started: Jul 3, 2025 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT07036250
Clinical Study of U32 in Patients With Acute Myeloid Leukemia
PHASE1/PHASE2Recruiting
20 participants
Started: Jul 3, 2025 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT07079839
A Neurosensory Account of Anxiety and Stress (Study 2)
NARecruiting
160 participants
Started: Jul 3, 2025 · Completed: Jul 31, 2026
2 conditions2 sponsors1 location
NCT06121050
Can a Patient in Intensive Care be Visited by His or Her Pet?
NARecruiting
30 participants
Started: Jul 3, 2025 · Completed: Jun 30, 2029
1 condition1 sponsor2 locations
NCT07059351
Oral Status as Predictors of Stroke-Associated Pneumonia and Swallowing Recovery in Patients With Post-Stroke Dysphagia
N/ARecruiting
260 participants
Started: Jul 2, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT07069504
Comparing AI Role-Play and Peer Role-Play for Informed Consent Training in Endoscopy: A Randomized Control Trial
NARecruiting
40 participants
Started: Jul 2, 2025 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT06759701
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study
EARLY_PHASE1Recruiting
30 participants
Started: Jul 2, 2025 · Completed: Dec 31, 2028
2 conditions1 sponsor1 location
NCT06998043
Study With Phage for CF Subjects With Pseudomonas Lung Infection
PHASE2Recruiting
63 participants
Started: Jul 2, 2025 · Completed: Sep 30, 2026
2 conditions1 sponsor14 locations
NCT06947694
A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases
PHASE2Recruiting
427 participants
Started: Jul 2, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT07033832
Acceptance and Commitment Therapy-based Intervention for Parents of a Child With Medical Complexity
NARecruiting
30 participants
Started: Jul 2, 2025 · Completed: Jun 30, 2026
6 conditions1 sponsor2 locations
NCT07063511
Pan-Facial Layering of Hyaluronic Acid Filler
NARecruiting
30 participants
Started: Jul 2, 2025 · Completed: Aug 2, 2026
1 condition1 sponsor1 location
NCT06972420
Improving the Quality of Anesthesia Induction by Reducing Preoperative Anxiety in the Operating Room
NARecruiting
60 participants
Started: Jul 2, 2025 · Completed: Oct 2, 2026
1 condition1 sponsor1 location
NCT06601712
Post-discharge Malaria Chemoprevention Implementation Trial in Benin
PHASE4Recruiting
648 participants
Started: Jul 2, 2025 · Completed: Dec 31, 2026
2 conditions7 sponsors2 locations
NCT06649695
A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis
PHASE2Recruiting
30 participants
Started: Jul 2, 2025 · Completed: Sep 30, 2028
1 condition2 sponsors10 locations
NCT06504277
Low Versus Standard Pressure Pneumoperitoneum on Shoulder Tip Pain
NARecruiting
82 participants
Started: Jul 2, 2025 · Completed: Sep 15, 2026
6 conditions2 sponsors1 location
NCT05802121
Akkermansia Muciniphilia and Metabolic Side Effects of ADT
EARLY_PHASE1Recruiting
30 participants
Started: Jul 2, 2025 · Completed: Jun 30, 2027
7 conditions1 sponsor1 location
NCT06708182
SAGE LEAF 2: An Online Program to Reduce Dementia Caregiver Burden
NARecruiting
140 participants
Started: Jul 2, 2025 · Completed: Jun 30, 2026
2 conditions3 sponsors1 location
NCT06908694
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
PHASE4Recruiting
20 participants
Started: Jul 2, 2025 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT07091292
Exercise Intervention as Treatment for People Using Cannabis (ExIT-C)
NARecruiting
60 participants
Started: Jul 2, 2025 · Completed: Dec 31, 2028
3 conditions1 sponsor1 location
NCT07089927
Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial
NARecruiting
20 participants
Started: Jul 2, 2025 · Completed: Jul 15, 2026
1 condition1 sponsor2 locations
NCT07062159
Psychoeducational Intervention to Reduce Depressive Symptoms and Strengthen Mother-Infant Bonding
NARecruiting
88 participants
Started: Jul 2, 2025 · Completed: Nov 1, 2025
3 conditions1 sponsor1 location
NCT07063212
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
PHASE2Recruiting
40 participants
Started: Jul 2, 2025 · Completed: Jan 2, 2028
12 conditions2 sponsors7 locations
NCT06231654
Evaluation of Remote Photoplethysmography to Assist Vital Signs Measure in Pediatrics
NARecruiting
600 participants
Started: Jul 2, 2025 · Completed: Jul 2, 2026
1 condition1 sponsor2 locations
NCT06876168
Virtual Reality in ICU - PARTNER
N/ARecruiting
32 participants
Started: Jul 2, 2025 · Completed: Sep 30, 2026
2 conditions2 sponsors1 location
NCT07052903
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
PHASE3Recruiting
1,250 participants
Started: Jul 2, 2025 · Completed: Nov 30, 2032
1 condition1 sponsor17 locations
NCT07095660
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)
NARecruiting
20 participants
Started: Jul 2, 2025 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
PHASE3Recruiting
13,000 participants
Started: Jul 2, 2025 · Completed: Jul 31, 2035
1 condition1 sponsor140 locations
NCT07079397
Hyaluronic Acid Filler Migration
NARecruiting
10 participants
Started: Jul 2, 2025 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT06976229
Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial
PHASE1Recruiting
12 participants
Started: Jul 2, 2025 · Completed: May 30, 2028
7 conditions2 sponsors1 location
NCT06422338
A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)
NARecruiting
5,212 participants
Started: Jul 2, 2025 · Completed: Mar 1, 2027
3 conditions1 sponsor1 location
NCT06984484
Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease
NARecruiting
208 participants
Started: Jul 2, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor6 locations
NCT06651593
Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors
PHASE2Recruiting
40 participants
Started: Jul 2, 2025 · Completed: Sep 1, 2030
1 condition3 sponsors1 location
NCT07195838
Mindful-Breath for People With COPD
NARecruiting
60 participants
Started: Jul 2, 2025 · Completed: May 30, 2027
3 conditions2 sponsors1 location
NCT06608277
Ketamine, SGB and Combination Treatment for TBI
PHASE2Recruiting
175 participants
Started: Jul 2, 2025 · Completed: Apr 30, 2028
2 conditions4 sponsors3 locations
NCT07104396
Cogito: A Turnkey Solution for Rapidly Developing, Evaluating, Deploying, and Scaling Digital Therapeutics
N/ARecruiting
20 participants
Started: Jul 2, 2025 · Completed: Aug 31, 2025
1 condition2 sponsors1 location
NCT06906497
Lebrikizumab in Moderate-to-severe Atopic Dermatitis
PHASE4Recruiting
48 participants
Started: Jul 2, 2025 · Completed: Jul 31, 2027
1 condition3 sponsors4 locations
NCT06825715
Multilevel Intervention for Precision Oncology
NARecruiting
2,653 participants
Started: Jul 2, 2025 · Completed: Feb 28, 2030
2 conditions9 sponsors1 location
NCT07098806
Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
PHASE1Recruiting
24 participants
Started: Jul 2, 2025 · Completed: Oct 2, 2031
1 condition1 sponsor1 location
NCT06706102
Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector Cell-Associated Neurotoxicity Syndrome
PHASE4Recruiting
60 participants
Started: Jul 2, 2025 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT07147933
"Effect of Treatment on Cerebral Palsy Patient With Crouch Gait Associated With Anterior Pelvic Tilt and Soleus Muscle WeaknessMarouf Syndrome, and Muscle Assesment by Using EMG"
NARecruiting
40 participants
Started: Jul 2, 2025 · Completed: Oct 2, 2025
5 conditions1 sponsor1 location
NCT07057245
Effects of Protein Supplementation on Brain Function
NARecruiting
25 participants
Started: Jul 2, 2025 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location
NCT07047586
Lenvatinib Plus Tislelizumab Versus Lenvatinib Alone in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab
PHASE2Recruiting
146 participants
Started: Jul 2, 2025 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT06981078
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD
PHASE2Recruiting
666 participants
Started: Jul 2, 2025 · Completed: Jul 31, 2028
1 condition1 sponsor323 locations
NCT07136220
A Pilot Study to Evaluate Equol and Its Effects on Menopausal Symptoms Experienced by Women in Singapore
N/ARecruiting
300 participants
Started: Jul 2, 2025 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT07046611
Ketamine and Levetiracetam as Second-line Antiseizure Medication for Status Epilepticus in Children
PHASE2/PHASE3Recruiting
124 participants
Started: Jul 2, 2025 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT07154641
Latissimus Dorsi Tendon Transfer vs. Superior Capsular Reconstruction in Massive Rotator Cuff Tears
NARecruiting
44 participants
Started: Jul 2, 2025 · Completed: May 31, 2029
1 condition1 sponsor1 location
NCT07048769
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
PHASE4Recruiting
246 participants
Started: Jul 2, 2025 · Completed: Jul 31, 2026
1 condition1 sponsor1 location